EKF Diagnostics scoops contract

EKF Diagnostics, a manufacturer of medical devices, has been awarded a contract to supply the State of New Mexico's Women, Infants, and Children (WIC) clinics with its point-of-care haemoglobin testing instrument.

The initial order is for 220 instruments which will be supplied to over 100 WIC clinics throughout the US State and will be used to carry out tests for anemia.

Anemia is one of the most common blood conditions in the US, affecting about 3.5m Americans.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

An initial indication from the New Mexico WIC clinics suggests that they expect to perform more than 160,000 tests per year using the HemoPoint H2 instrument.

Julian Baines, Chief Executive of EKF, said: "Following on from our recent trading update, which showed strong trading for 2011 ahead of expectations, the news of this contract win reinforces our belief that EKF will deliver continued organic growth in 2012, particularly as we ramp up sales of our HemoPoint H2 instruments in the key market of North America."

The share price rose 5% to 26.25p by 09:36.

NR